A compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents are defined herein, and methods of treating HCV infection in a patient are disclosed.
-
Page/Page column 60; 61
(2013/07/05)
More Articles about upstream products of 1443930-14-0